| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |